3D bioprinter material developer CollPlant (NASDAQ:CLGN) has confirmed an investment of $5.5 million. Provided by a group of investors with special interest in the 3D printing industry and Ami Sagi, the company’s largest shareholder, the deal was confirmed September 9, 2019. $3.5 million in convertible loans was provided by the anonymous investor group, whereas the remaining $2 […]
71 Replies to “CollPlant 3D bioprinted materials business closes $5.5M in funding”
Comments are closed.